Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Synopsis

Nature Medicine, Published online: 27 October 2026; doi:10.1038/s41591-026-04751-6 Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

The publisher’s own description. This is a short summary, not the full story, and may omit important detail.